Similarly, a meta-analysis investigating the relationship of GST polymorphisms with ovarian cancer risk suggested that the role of GSTs is highly significant in drug-resistant tumours where the higher expression of GSTs could alter the control of the kinase cascade during drug therapy [133]. Here, HPGDS is linked to neoplasm.